Back

Cardiac presentation and treatment response by sex in patients with transthyretin amyloidosis: pooled analysis of vutrisiran and patisiran phase 3 studies

31 August 2026 (10:00 - 10:10)
Organised by: Logo
Congress Presentation Part of: Improving care in cardiac amyloidosis Infiltrative Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Assistant Professor Amira Zaroui

University Hospital Henri Mondor, Creteil (France)

5 More presentations in this session

Presentation thumbnail
Novel blood-based biomarkers for transthyretin amyloidosis with cardiomyopathy (ATTR-CM) in patients heart failure with preserved ejection fraction
Doctor H. Gaggin (Boston, US)
Abstract
Presentation thumbnail
In vivo gene editing with YOLT-201 for transthyretin amyloid cardiomyopathy – an open-label, first-in-human clinical trial
Doctor H. Yan (Hangzhou, CN)
Abstract
Presentation thumbnail
Assessing generalizability of an AI model for cardiac amyloidosis detection in ECGs: interim results of a multi-centre, external validation study
Assistant Professor F. Ahmad (Chicago, US)
Abstract
Presentation thumbnail
Prognostic value of CT-derived pectoralis muscle area in tafamidis-treated ATTRwt cardiomyopathy
Doctor K. Ayai (JP)
Abstract
Presentation thumbnail
Recurrence of transthyretin amyloid cardiomyopathy following heart transplantation - a long term follow-up analysis
Doctor M. Poledniczek (Vienna, AT)
Abstract

Access the full session

Session thumbnail
Improving care in cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

31 August 2026 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Transthyretin-directed antisense oligonucleotide therapy effects on ATTRv myocardiopathy
20 May 2023
thumbnail
Congress Presentation
Impact of sex on the burden of sustained ventricular tachyarrhythmic events following LVAD implant: preliminary data from the PIVATAL Trial
14 April 2026
thumbnail
Congress Presentation
Unraveling gender differences in hereditary transthyretin amyloidosis: insights from the REACT registry
31 August 2025
thumbnail
Congress Presentation
Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes
28 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources